G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 1 057.2 INR 2.9% Market Closed
Market Cap: 129.5B INR
Have any thoughts about
Glenmark Life Sciences Ltd?
Write Note

Glenmark Life Sciences Ltd
Other Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Glenmark Life Sciences Ltd
Other Receivables Peer Comparison

Comparables:
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
M
MANKIND

Competitive Other Receivables Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
G
Glenmark Life Sciences Ltd
NSE:GLS
Other Receivables
â‚ą1.1B
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Other Receivables
â‚ą2.4m
CAGR 3-Years
-55%
CAGR 5-Years
-48%
CAGR 10-Years
-54%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Other Receivables
â‚ą650.2m
CAGR 3-Years
5%
CAGR 5-Years
-27%
CAGR 10-Years
-26%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Other Receivables
â‚ą8.2B
CAGR 3-Years
N/A
CAGR 5-Years
141%
CAGR 10-Years
12%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Other Receivables
â‚ą30.5m
CAGR 3-Years
-1%
CAGR 5-Years
-4%
CAGR 10-Years
-28%
M
Mankind Pharma Ltd
NSE:MANKIND
Other Receivables
â‚ą859.7m
CAGR 3-Years
-29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Glenmark Life Sciences Ltd's Other Receivables?
Other Receivables
1.1B INR

Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Other Receivables amounts to 1.1B INR.

What is Glenmark Life Sciences Ltd's Other Receivables growth rate?
Other Receivables CAGR 5Y
10%

Over the last year, the Other Receivables growth was 0%. The average annual Other Receivables growth rates for Glenmark Life Sciences Ltd have been 1% over the past three years , 10% over the past five years .

Back to Top